Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxicologic evaluation of bumetanide, potent diuretic agent

R M McClain, K D Dammers

    Journal of Clinical Pharmacology
    |November 1, 1981
    PubMed
    Summary

    Bumetanide, a loop diuretic, was well tolerated in preclinical toxicity studies across multiple species. Observed toxicities were primarily linked to its diuretic effects, with no teratogenic or mutagenic activity found.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.

    Human & experimental toxicology·2006
    Same author

    Neonatal mouse model: review of methods and results.

    Toxicologic pathology·2001
    Same author

    Vitamin D3-induced proliferative lesions in the rat adrenal medulla.

    Toxicological sciences : an official journal of the Society of Toxicology·1999
    Same author

    A mechanistic relationship between thyroid follicular cell tumours and hepatocellular neoplasms in rodents.

    IARC scientific publications·1999
    Same author

    Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.

    Toxicology and applied pharmacology·1998
    Same author

    5-methylcytosine is present in the 5' flanking region of Ha-ras in mouse liver and increases with ageing.

    International journal of cancer·1997

    Area of Science:

    • Pharmacology
    • Toxicology
    • Drug Safety

    Background:

    • Bumetanide is a potent loop diuretic used clinically.
    • Preclinical safety data is essential for understanding potential human risks.

    Purpose of the Study:

    • To conduct a comprehensive preclinical toxicologic evaluation of bumetanide.
    • To assess the safety profile of bumetanide in various animal models.

    Main Methods:

    • Acute and chronic toxicity studies were performed in rats, rabbits, dogs, and baboons.
    • Reproductive toxicity, mutagenicity (Ames test), and carcinogenicity studies were conducted.

    Main Results:

    • Bumetanide was generally well tolerated, with toxicities mainly related to its diuretic action.
    • Fetotoxicity was observed in rabbits at maternally toxic doses, but no teratogenic effects were noted.
    • The compound showed no mutagenic or carcinogenic potential in the evaluated studies.

    Conclusions:

    • Bumetanide exhibits a safety profile consistent with other loop diuretics.
    • The preclinical data supports the established use of bumetanide while highlighting potential risks associated with high doses.

    Related Experiment Videos